Saúde Pública/Medicina Humanitária

Perspectiva | Reforços da vacina contra COVID-19 em nações ricas atrasará a vacinação para todos.

2 Set, 2021 | 11:48h

COVID-19 boosters in rich nations will delay vaccines for all – Nature

Comentários no Twitter

In @NatureMedicine, @zchagla & I ask:

Are we as a species willing to protect all humankind, or do we mostly care about optimizing protection for people in wealthy nations?https://t.co/LCS5Dxf1II pic.twitter.com/vdn4oRiYyz

— Madhu Pai, MD, PhD (@paimadhu) August 31, 2021

"There remain 3.5 billion people on this earth, nearly half of the world’s population, who have not received even a first dose of vaccine. Only 2% of the African population has received even a single dose." #Equity #COVID19 Via @NatureMedicine https://t.co/k6cG6vyQ5d pic.twitter.com/DsbWVvQ9R7

— Muin J. Khoury (@MuinJKhoury) August 31, 2021

Prioritising COVID booster shots in high income countries is unethical – until health care workers and those at high risk in low and middle income countries have been vaccinated. @paimadhu and @zchagla wrote this much better than I could – thank you! https://t.co/F89o8y9V8P

— Ben Johnson 🦠📝 (@drbenjohnson) August 31, 2021

COVID pode ser mais infecciosa nos 2 ou 3 dias próximos ao início dos sintomas.

2 Set, 2021 | 11:43h

COVID may be most infectious 2 or 3 days around symptom onset – CIDRAP

Artigo original: COVID-19 Transmission Dynamics Among Close Contacts of Index Patients With COVID-19: A Population-Based Cohort Study in Zhejiang Province, China – JAMA Internal Medicine

Estudo randomizado | A vacinação sazonal e a combinação de medicamentos preventivos reduziu drasticamente os casos de malária grave entre crianças pequenas na África.

2 Set, 2021 | 11:35h

Comunicado de imprensa: Severe malaria among young African children dramatically reduced through seasonal vaccination and preventative drug combination – London School of Hygiene & Tropical Medicine

Artigo original: Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention – New England Journal of Medicine

Comentário: Malaria trial shows ‘striking’ 70% reduction in severe illness in children – The Guardian

Conteúdo relacionado: Malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal

Estimativas e tendências globais, regionais e nacionais de natimortos de 2000 a 2019: uma avaliação sistemática.

2 Set, 2021 | 11:31h

Global, regional, and national estimates and trends in stillbirths from 2000 to 2019: a systematic assessment – The Lancet

Estudo demonstra imunogenicidade humoral significativamente mais alta induzida pela vacina da Moderna em comparação à vacina da Pfizer- BioNTech.

2 Set, 2021 | 11:28h

Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273 – JAMA

Conteúdos relacionados:

Moderna may be superior to Pfizer against Delta variant — breakthrough odds rise with time.

[Preprint] Pfizer vs. Moderna COVID-19 vaccine effectiveness against the Delta variant in Qatar – Effectiveness against symptomatic disease due to Delta was 53.5% for Pfizer and 84.8% for Moderna; effectiveness against severe disease due to Delta was 89.7% for Pfizer and 100.0% for Moderna.

OMS emite diretrizes para o “passaporte digital” da vacina contra COVID-19 – mas destaca que ele não deve ser requisito para viagens.

2 Set, 2021 | 11:26h

WHO Issues COVID-19 Digital ‘Vaccine Pass’ Guidelines – But Stresses These Should Not be Requirements for Travel – Health Policy Watch

Ver diretriz: Digital documentation of COVID-19 certificates: vaccination status: technical specifications and implementation guidance, 27 August 2021 – World Health Organization

Estudo mostra que as crianças ganharam peso durante a pandemia.

2 Set, 2021 | 11:22h

News release: Young children gained weight during the pandemic – Kaiser Permanente

Estudo original: Changes in Body Mass Index Among Children and Adolescents During the COVID-19 Pandemic – JAMA

Comentário no Twitter

#KPResearch showed significant weight gain occurred during COVID-19 pandemic among youth in Southern California, especially among youngest kids.
Research: @KPSCalResearch & @UMchear
In @JAMANetwork
Authors incl @CKoebnickPhD @RohmDeborah @MargoSidell https://t.co/IqiUxo75bW pic.twitter.com/8XA7G6J3Bu

— Kaiser Permanente Research (@KPSCalResearch) August 27, 2021

Crianças têm “long COVID”? E com qual frequência? Um pediatra analisa os dados e conclui que crianças também têm “long COVID”, mas muito menos que os adultos.

2 Set, 2021 | 11:19h

Do kids get long COVID? And how often? A paediatrician looks at the data – The Conversation

Conteúdos relacionados:

Illness duration and symptom profile in symptomatic school-aged children tested for SARS-CoV-2 – “Only 25 (1.8%) of 1379 children experienced symptoms for at least 56 days.”

Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents – “This study found a low prevalence of symptoms compatible with long COVID in a randomly selected cohort of children assessed 6 months after serologic testing”.

Study shows low incidence of post-acute COVID-19 symptoms (“Long Covid”) in children after mild disease

Cohort study: Risk factors for long covid in previously hospitalized children.

M-A: More than 50 long-term effects of COVID-19.

Opinião | Vacinas contra COVID: precisamos descobrir quais incentivos funcionam de fato – os autores argumentam que políticas para promover a adesão às vacinas devem ser testadas em estudos clínicos randomizados.

2 Set, 2021 | 11:17h

COVID vaccines: we need to find out which incentives actually work – The Conversation

#ESCCongress – Estudo randomizado | Vacinação precoce contra Influenza após infarto do miocárdio (IM) ou em doença coronariana de alto risco resultou em menor risco de morte por todas as causas, IM ou trombose de stent em comparação com placebo.

2 Set, 2021 | 11:13h

Influenza Vaccination after Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial – Circulation

Comentários:

IAMI: Influenza Vaccine Beneficial for Post-MI Patients – TCTMD

Influenza Vaccination After Myocardial Infarction – IAMI – American College of Cardiology

Flu vaccine after heart attack reduces risk of death – Cardiovascular Business